HRP20110890T4 - Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja - Google Patents

Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja

Info

Publication number
HRP20110890T4
HRP20110890T4 HRP20110890AT HRP20110890T HRP20110890T4 HR P20110890 T4 HRP20110890 T4 HR P20110890T4 HR P20110890A T HRP20110890A T HR P20110890AT HR P20110890 T HRP20110890 T HR P20110890T HR P20110890 T4 HRP20110890 T4 HR P20110890T4
Authority
HR
Croatia
Prior art keywords
unfermed
aspalatine
dihydrocalcon
bulgaria
extremes
Prior art date
Application number
HRP20110890AT
Other languages
English (en)
Croatian (hr)
Inventor
Bruno Frank
Wilfried Dimpfel
Original Assignee
Kneipp Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38805677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110890(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kneipp Gmbh filed Critical Kneipp Gmbh
Publication of HRP20110890T1 publication Critical patent/HRP20110890T1/hr
Publication of HRP20110890T4 publication Critical patent/HRP20110890T4/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
HRP20110890AT 2007-10-23 2008-09-05 Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja HRP20110890T4 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07020728A EP2053050B1 (de) 2007-10-23 2007-10-23 Aspalathin-ähnliches Dihydrochalcon und Verfahren zur Herstellung
EP08801873.4A EP2069334B2 (de) 2007-10-23 2008-09-05 Aspalathin-ähnliches dihydrochalcon, extrakte aus unfermentiertem rotbusch und verfahren zur herstellung
PCT/EP2008/007279 WO2009052895A1 (de) 2007-10-23 2008-09-05 Aspalathin-ähnliches dihydrochalcon, extrakte aus unfermentiertem rotbusch und verfahren zur herstellung

Publications (2)

Publication Number Publication Date
HRP20110890T1 HRP20110890T1 (hr) 2011-12-31
HRP20110890T4 true HRP20110890T4 (xx) 2015-02-27

Family

ID=38805677

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20110890AT HRP20110890T4 (xx) 2007-10-23 2008-09-05 Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja

Country Status (10)

Country Link
US (1) US20100222423A1 (enExample)
EP (2) EP2053050B1 (enExample)
JP (1) JP5527900B2 (enExample)
AT (2) ATE522524T1 (enExample)
DK (2) DK2053050T3 (enExample)
ES (2) ES2372203T3 (enExample)
HR (1) HRP20110890T4 (enExample)
PL (2) PL2053050T3 (enExample)
PT (2) PT2053050E (enExample)
WO (1) WO2009052895A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2368560A1 (en) 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos
WO2016072522A1 (ja) * 2014-11-06 2016-05-12 国立大学法人 長崎大学 新規アルツハイマー病治療薬
JP6735224B2 (ja) * 2016-01-28 2020-08-05 花王株式会社 アストロサイトのグルコース代謝活性化剤
JP7244273B2 (ja) * 2018-12-27 2023-03-22 株式会社 伊藤園 ルイボス茶飲料の製造方法
CN109932448A (zh) * 2019-03-29 2019-06-25 完美（广东）日用品有限公司 一种线叶金雀花及其制品中有效成分的含量测定方法
CN115104730A (zh) * 2022-06-28 2022-09-27 北京姿美堂生物技术股份有限公司 一种改善睡眠的组合物、线叶金雀花-芦笋睡眠改善液、茶粉的制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2895298B2 (ja) * 1991-12-27 1999-05-24 株式会社ユニエ 活性酸素消去・除去剤
JPH05246866A (ja) * 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 脳代謝促進・脳機能改善剤
JPH11116429A (ja) † 1997-10-13 1999-04-27 Mikimoto Pharmaceut Co Ltd 化粧品原料および化粧品
JP2001316239A (ja) * 2000-05-10 2001-11-13 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
KR100421233B1 (ko) * 2001-09-10 2004-03-11 한국원자력연구소 식품, 의약품 및 화장품 제조용 천연물의 색도 개선 방법 및 이의 방법에 의해 색도가 개선된 천연물 추출물
ZA200303674B (en) * 2002-02-20 2005-04-26 Benedict Technology Holdings P Antioxidant composition.
JP4637491B2 (ja) * 2004-03-01 2011-02-23 株式会社東洋発酵 抗アレルギー用組成物
DE102004052800B4 (de) * 2004-10-30 2017-02-23 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verbesserte Trägerformulierungen
DE102005004438B4 (de) * 2005-01-31 2007-12-20 Raps Gmbh & Co. Kg Rooibos-Extrakt mit erhöhtem Aspalathingehalt, Verfahren zur Herstellung eines solchen Rooibos-Extraktes und kosmetisches Mittel enthaltend einen solchen Rooibos-Extrakt
JP2007161661A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc アドバンスド・グリケーション・エンドプロダクツを分解するための化粧料とその製造法
EP2368560A1 (en) † 2007-03-12 2011-09-28 Zadec ApS An anti-diabetic extract of rooibos

Also Published As

Publication number Publication date
JP5527900B2 (ja) 2014-06-25
DK2069334T4 (da) 2014-12-08
PT2069334E (pt) 2011-12-30
US20100222423A1 (en) 2010-09-02
EP2053050A1 (de) 2009-04-29
PL2053050T3 (pl) 2012-01-31
EP2069334B1 (de) 2011-11-16
EP2069334B2 (de) 2014-11-05
HRP20110890T1 (hr) 2011-12-31
ATE533763T1 (de) 2011-12-15
DK2053050T3 (da) 2011-11-21
ATE522524T1 (de) 2011-09-15
WO2009052895A1 (de) 2009-04-30
EP2053050B1 (de) 2011-08-31
ES2372203T3 (es) 2012-01-17
PT2053050E (pt) 2011-12-09
ES2373509T5 (es) 2015-02-16
PL2069334T5 (pl) 2015-06-30
PL2069334T3 (pl) 2012-04-30
ES2373509T3 (es) 2012-02-06
EP2069334A1 (de) 2009-06-17
DK2069334T3 (da) 2012-01-23
JP2011501755A (ja) 2011-01-13

Similar Documents

Publication Publication Date Title
DK2069334T3 (da) Aspalathin-lignende dihydrochalcon, ekstrakter af ufermenteret rooibos og fremgangsmåde til fremstilling
EP2178869A4 (en) INDOL COMPOUNDS AS AN INHIBITORS OF CELL NECROSIS
MX2010003711A (es) Derivados de tetrahidroquinolina para tratar trastornos por estres post-traumatico.
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
SI2182949T1 (sl) (2S,3R)-N-(2-((3-piridinil)metil)-1-azabiciklo(2.2.2)okt-3-il)benzofuran -2-karboksamid, nove oblike soli in postopki za njihovo uporabo
AR053334A1 (es) Pirazolilcarboxanilidas
IL212351A (en) Non-hygroscopic crystalline forms of (r) –5– [3– chloro – 4– (3,2 – dihydroxy – propoxy) –benz [z] yladen] –2 - ([z] - profileimino) –3– o– tolyl -Tiazolidine-4-On, containing between 0 and 0.5 equivalents of water to the equivalent molecule, pharmaceutical preparations and their uses
DOP2006000170A (es) Nuevos derivados de espirocromanona
UA106199C2 (ru) Производные аминобензамида как агенты, пригодные для использования для борьбы с паразитами животных
WO2011014825A3 (en) Antiangiogenic small molecules and methods of use
EP2146688A4 (en) COSMETIC COMPOSITION FOR LIGHTING UP THE SKIN WITH MAGNOLIA SIEBOLDII EXTRACT AS AN ACTIVE SUBSTANCE
WO2010128050A3 (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds
UA104598C2 (ru) Гербицидная композиция и способ ее применения
CL2007003832A1 (es) Compuestos derivados de azaespiro; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir y tratar ansiedad, trastornos depresivos, entre otras enfermedades.
CL2007000918A1 (es) Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica.
MY163501A (en) Anti-biofilm carbonate compouns for use in oral care compositions
WO2009060952A1 (ja) 新規製剤
CO6361848A2 (es) Composición para controlar enfermedades vegetales y metodo para controlar enfermedades vegetales
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
ZA201101579B (en) Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
NZ600266A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
GEP20115309B (en) Acid addition salts, hydrates and polymorphs of 5-(2,4-dihy-droxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-arboxylic acid ethylamide and formulations comprising these forms
UY30653A1 (es) Antiinflamatorios no esteroideos contra la tos
GEP20125646B (en) 3-(2,2,2-trimethylhydrazinium) propionate salts for ischemic heart disease treatment
WO2011075799A3 (en) Oral antidepressant formulation